| A genome-wide map of diversity in Plasmodium falciparum SK Volkman, PC Sabeti, D DeCaprio, DE Neafsey, SF Schaffner, ... Nature genetics 39 (1), 113-119, 2007 | 402 | 2007 |
| Clinical sequencing uncovers origins and evolution of Lassa virus KG Andersen, BJ Shapiro, CB Matranga, R Sealfon, AE Lin, LM Moses, ... Cell 162 (4), 738-750, 2015 | 285 | 2015 |
| Diversity-oriented synthesis yields novel multistage antimalarial inhibitors N Kato, E Comer, T Sakata-Kato, A Sharma, M Sharma, M Maetani, ... Nature 538 (7625), 344-349, 2016 | 250 | 2016 |
| Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics AN Cowell, ES Istvan, AK Lukens, MG Gomez-Lorenzo, M Vanaerschot, ... Science 359 (6372), 191-199, 2018 | 216 | 2018 |
| Genome-wide SNP genotyping highlights the role of natural selection in Plasmodium falciparumpopulation divergence DE Neafsey, SF Schaffner, SK Volkman, D Park, P Montgomery, ... Genome biology 9, 1-16, 2008 | 147 | 2008 |
| In Vivo Transcriptome of Plasmodium falciparum Reveals Overexpression of Transcripts That Encode Surface Proteins JP Daily, KG Le Roch, O Sarr, D Ndiaye, A Lukens, Y Zhou, O Ndir, ... The Journal of infectious diseases 191 (7), 1196-1203, 2005 | 131 | 2005 |
| Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite DJ Park, AK Lukens, DE Neafsey, SF Schaffner, HH Chang, C Valim, ... Proceedings of the National Academy of Sciences 109 (32), 13052-13057, 2012 | 128 | 2012 |
| A broad analysis of resistance development in the malaria parasite VC Corey, AK Lukens, ES Istvan, MCS Lee, V Franco, P Magistrado, ... Nature communications 7 (1), 11901, 2016 | 115 | 2016 |
| Identification and Functional Validation of the Novel Antimalarial Resistance Locus PF10_0355 in Plasmodium falciparum D Van Tyne, DJ Park, SF Schaffner, DE Neafsey, E Angelino, JF Cortese, ... PLoS genetics 7 (4), e1001383, 2011 | 113 | 2011 |
| Open-source discovery of chemical leads for next-generation chemoprotective antimalarials Y Antonova-Koch, S Meister, M Abraham, MR Luth, S Ottilie, AK Lukens, ... Science 362 (6419), eaat9446, 2018 | 110 | 2018 |
| Genetic surveillance detects both clonal and epidemic transmission of malaria following enhanced intervention in Senegal R Daniels, HH Chang, PD Séne, DC Park, DE Neafsey, SF Schaffner, ... PloS one 8 (4), e60780, 2013 | 110 | 2013 |
| The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs JD Herman, LR Pepper, JF Cortese, G Estiu, K Galinsky, V Zuzarte-Luis, ... Science translational medicine 7 (288), 288ra77-288ra77, 2015 | 99 | 2015 |
| Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance AK Lukens, LS Ross, R Heidebrecht, F Javier Gamo, ... Proceedings of the National Academy of Sciences 111 (2), 799-804, 2014 | 72 | 2014 |
| Diversity-oriented synthesis yields a novel lead for the treatment of malaria RW Heidebrecht Jr, C Mulrooney, CP Austin, RH Barker Jr, JA Beaudoin, ... ACS medicinal chemistry letters 3 (2), 112-117, 2012 | 72 | 2012 |
| Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate S Hameed P, S Solapure, V Patil, PP Henrich, PA Magistrado, S Bharath, ... Nature Communications 6 (1), 6715, 2015 | 68 | 2015 |
| MalDA, accelerating malaria drug discovery T Yang, S Ottilie, ES Istvan, KP Godinez-Macias, AK Lukens, B Baragaña, ... Trends in parasitology 37 (6), 493-507, 2021 | 54 | 2021 |
| New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections M McPhillie, Y Zhou, K El Bissati, J Dubey, H Lorenzi, M Capper, ... Scientific reports 6 (1), 29179, 2016 | 54 | 2016 |
| New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections M McPhillie, Y Zhou, K El Bissati, J Dubey, H Lorenzi, M Capper, ... Scientific reports 6 (1), 29179, 2016 | 54 | 2016 |
| Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes PA Magistrado, VC Corey, AK Lukens, G LaMonte, E Sasaki, S Meister, ... ACS infectious diseases 2 (11), 816-826, 2016 | 44 | 2016 |
| Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents E Comer, JA Beaudoin, N Kato, ME Fitzgerald, RW Heidebrecht, ... Journal of medicinal chemistry 57 (20), 8496-8502, 2014 | 44 | 2014 |
